Ciprofloxacin for respiratory tract infection with Pseudomonas aeruginosa
- 17 Downloads
Thirty one patients were treated with oral ciprofloxacin for bronchitis withPseudomonas aeruginosa. Twenty eight patients had permanent and 14 transient risk factors. Nine patients had a hospital infection withPseudomonas aeruginosa. Sixteen patients were cured, complete or partial, butPseudomonas aeruginosa persisted or recurred in 19 patients. Patients with hospital infection did better than other patients. There was a significant decrease inin vitro susceptibility of persisting strains ofPseudomonas aeruginosa to ciprofloxacin and a tendency of recovery of susceptibility for the drug after treatment.
Key wordsBronchitis Ciprofloxacin Clinical evaluation Drug evaluation Hospital infection In vitro susceptibility
- 2.Lennette EH, Balows A, Hauser WJ, Shadomy HJ. Manual of Clinical Microbiology 4th ed. Washington, D.C.: Am Soc Microbiol 1985.Google Scholar